Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-10

Clinical Trial Update: Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2 and Phase 3 trial evaluating transplantation of bone marrow–derived mesenchymal stem cells for knee osteoarthritis associated with rheumatoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED